(1)
Moreno, C.; Aiello, A.; Di Virgilio, R.; Mazzotta, V.; Antinori, A. Cost-Effectiveness Analysis of nirmatrelvir/Ritonavir in Adult Patients at High Risk of Progressing to Severe COVID-19. Grhta 2025, 11, 168-176.